Washington was supposed to lower drug prices in 2019. What happened?
Nearly everyone thought 2019 would be a big year for drug pricing. But neither Congress nor the White House enacted major policies to bring down costs.
Related Articles
What pharma companies and insurers think about Medicare’s plan to cover digital treatments
Developers of digital treatments have been lobbying for Medicare coverage for years.
A documentary film asks: Can health systems improve patient safety by embracing new tech?
“The Pitch,” spotlights how a new generation of technology stands to improve patient safety in the U.S.
House panel advances bill to extend Medicare’s telehealth flexibilities, setting up December talks
The bill would make more telehealth services available to Medicare enrollees in their homes nationwide.
House panel advances bill to extend Medicare’s telehealth flexibilities, setting up December talks
The bill would make more telehealth services available to Medicare enrollees in their homes nationwide.
11 people shaping psychedelics drug development
Here are 11 people to know in the psychedelics drug development industry.
The U.S. should follow California’s lead on banning toxic chemicals in IV bags and tubes
DEHP, a cancer-causing chemical, is widely present in IV devices used to treat cancer. California is poised to take action, and so should the rest…
In race to make gene therapy for age-related blindness, 4D Molecular announces positive results
While most gene therapy research has focused on rare disease, new results are out for a possible treatment for wet-AMD, the leading cause of age-related…
Senate IVF bill fails again as Democrats pressure GOP on reproductive health
Democrats are pursuing new attack lines ahead of an election that many see as a referendum on reproductive rights.
2024 STAT Summit
The STAT Summit is back in Boston October 16 & 17, 2024 — this year we’re examining change in medicine, why it’s so hard, &…
Kamala Harris’ views on health care were shaped by her mother, cancer researcher Shyamala Gopalan
Kamala Harris’ late mother, the prominent breast cancer researcher Shyamala Gopalan, helped shape the presidential candidate’s views on health and medicine.